Nivolumab in pre-treated malignant pleural mesothelioma: real-world data from the Dutch expanded access program

Real World ◽

Pleural Mesothelioma ◽

Real World Data ◽

World Data ◽

Expanded Access ◽

Expanded Access Program ◽

OA09.06 Nivolumab in Recurrent Malignant Pleural Mesothelioma: Real-World Data From Expanded Access Program In The Netherlands

Journal of Thoracic Oncology ◽

10.1016/j.jtho.2021.01.308 ◽

2021 ◽

Vol 16 (3) ◽

pp. S123

Author(s):

R. Belderbos ◽

L. Cantini ◽

C. Gooijer ◽

D. Dumoulin ◽

R. Cornelissen ◽

...

Keyword(s):

The Netherlands ◽

Real World ◽

Pleural Mesothelioma ◽

Real World Data ◽

World Data ◽

Expanded Access ◽

Expanded Access Program ◽

REACT expanded-access program in patients with metastatic renal cell carcinoma: real-world data from a European subanalysis

Future Oncology ◽

10.2217/fon.15.241 ◽

2015 ◽

Vol 11 (21) ◽

pp. 2893-2903 ◽

Cited By ~ 2

Author(s):

Sergio Bracarda ◽

Sylvie Rottey ◽

Amit Bahl ◽

Christian Eichelberg ◽

Begoña Mellado ◽

...

Keyword(s):

Renal Cell Carcinoma ◽

Cell Carcinoma ◽

Metastatic Renal Cell Carcinoma ◽

Real World ◽

Renal Cell ◽

Real World Data ◽

World Data ◽

Expanded Access ◽

Expanded Access Program ◽

1244P Durvalumab after definitive radiochemotherapy (RCT) in locally advanced unresectable NSCLC: Real-world data on survival and safety from the German expanded access program (EAP)

Annals of Oncology ◽

10.1016/j.annonc.2020.08.117 ◽

2020 ◽

Vol 31 ◽

pp. S806-S807 ◽

Cited By ~ 1

Author(s):

M. Faehling ◽

C. Schumann ◽

P. Christopoulos ◽

P. Hoffknecht ◽

J. Alt ◽

...

Keyword(s):

Real World ◽

Locally Advanced ◽

Real World Data ◽

World Data ◽

Expanded Access ◽

Expanded Access Program ◽

Access Program ◽

Definitive Radiochemotherapy

Single-Agent Pemetrexed for Chemonaïve and Pretreated Patients with Malignant Pleural Mesothelioma: Results of an International Expanded Access Program

Journal of Thoracic Oncology ◽

10.1097/jto.0b013e31817c73ec ◽

2008 ◽

Vol 3 (7) ◽

pp. 764-771 ◽

Cited By ~ 32

Author(s):

Paul Taylor ◽

Bruno Castagneto ◽

Graham Dark ◽

Maurizio Marangolo ◽

Giorgio V. Scagliotti ◽

...

Keyword(s):

Single Agent ◽

Pleural Mesothelioma ◽

Expanded Access ◽

Expanded Access Program ◽

Pretreated Patients ◽

Safety and efficacy of Cabozantinib for metastatic renal cell carcinoma (mRCC): real world data from an Italian Expanded Access Program (EAP)

Annals of Oncology ◽

10.1093/annonc/mdx371.055 ◽

2017 ◽

Vol 28 ◽

pp. v319-v320

Author(s):

G. Procopio ◽

M. Prisciandaro ◽

R. Iacovelli ◽

M. Mancini ◽

G. Fornarini ◽

...

Keyword(s):

Renal Cell Carcinoma ◽

Cell Carcinoma ◽

Metastatic Renal Cell Carcinoma ◽

Real World ◽

Renal Cell ◽

Real World Data ◽

Safety And Efficacy ◽

World Data ◽

Expanded Access Program ◽

Pemetrexed alone or in combination with cisplatin in previously treated patients with malignant pleural mesothelioma (MPM): Outcomes of an expanded access program (EAP)

Journal of Clinical Oncology ◽

10.1200/jco.2004.22.90140.7195 ◽

2004 ◽

Vol 22 (14_suppl) ◽

pp. 7195-7195

Author(s):

M. Orlando ◽

A. Wozniak ◽

P. Janne ◽

C. P. Belani ◽

M. L. Keohan ◽

...

Keyword(s):

Pleural Mesothelioma ◽

Expanded Access ◽

Expanded Access Program ◽

Previously Treated Patients ◽

Previously Treated ◽

Pemetrexed in combination with cisplatin in the treatment of chemonaive patients with malignant pleural mesothelioma (MPM): Outcomes on Expanded Access Program (EAP)

Journal of Clinical Oncology ◽

10.1200/jco.2004.22.14_suppl.7192 ◽

2004 ◽

Vol 22 (14_suppl) ◽

pp. 7192-7192 ◽

Cited By ~ 1

Author(s):

A. J. Wozniak ◽

P. Janne ◽

C. P. Belani ◽

M. L. Keohan ◽

H. Ross ◽

...

Keyword(s):

Pleural Mesothelioma ◽

Expanded Access ◽

Expanded Access Program ◽

Pemetrexed Alone or in Combination with Cisplatin in Previously Treated Malignant Pleural Mesothelioma: Outcomes from a Phase IIIB Expanded Access Program

Journal of Thoracic Oncology ◽

10.1097/01243894-200607000-00002 ◽

2006 ◽

Vol 1 (6) ◽

pp. 506-512 ◽

Cited By ~ 34

Author(s):

Pasi A. Jänne ◽

Antoinette J. Wozniak ◽

Chandra P. Belani ◽

Mary-Louise Keohan ◽

Helen J. Ross ◽

...

Keyword(s):

Pleural Mesothelioma ◽

Expanded Access ◽

Expanded Access Program ◽

Phase Iiib ◽

Previously Treated ◽

Single-arm, open label study of pemetrexed plus cisplatin in chemotherapy naïve patients with malignant pleural mesothelioma: Outcomes of an expanded access program

Lung Cancer ◽

10.1016/j.lungcan.2006.09.023 ◽

2007 ◽

Vol 55 (2) ◽

pp. 187-194 ◽

Cited By ~ 20

Author(s):

Coleman K. Obasaju ◽

Zhishen Ye ◽

Antoinette J. Wozniak ◽

Chandra P. Belani ◽

Mary-Louise Keohan ◽

...

Keyword(s):

Pleural Mesothelioma ◽

Open Label ◽

Open Label Study ◽

Label Study ◽

Expanded Access ◽

Expanded Access Program ◽

Pemetrexed alone or in combination with cisplatin in previously treated patients with malignant pleural mesothelioma (MPM): Outcomes of an expanded access program (EAP)

Journal of Clinical Oncology ◽

10.1200/jco.2004.22.14_suppl.7195 ◽

2004 ◽

Vol 22 (14_suppl) ◽

pp. 7195-7195 ◽

Cited By ~ 1

Author(s):

M. Orlando ◽

A. Wozniak ◽

P. Janne ◽

C. P. Belani ◽

M. L. Keohan ◽

...

Keyword(s):

Pleural Mesothelioma ◽

Expanded Access ◽

Expanded Access Program ◽

Previously Treated Patients ◽

Previously Treated ◽